Acute Radiation Syndrome

ARS Basics - Radiation's Rude Jolt

• Definition: Acute illness from whole-body/significant partial-body exposure to high-dose penetrating radiation over a short period.
• Nature: Deterministic effect; severity ↑ with dose. A threshold dose must be exceeded.
• Radiation Types: Gamma rays, X-rays, neutrons.
• Symptom Onset:

  ⭐ Whole-body absorbed dose > 1 Gy (100 rads) is generally required to produce symptoms of ARS.

• Key Factors: Total dose, dose rate, body area exposed, radiation quality, individual sensitivity.

ARS Phases & Dose - Timeline of Trouble

• 1. Prodromal Phase:
  • Onset: Mins-hrs post-exposure.
  • Symptoms: NVD (Nausea, Vomiting, Diarrhea), fatigue.
  • Dose: >1 Gy. Severity ↑ with dose.
• 2. Latent Phase:
  • Apparent wellness. Duration: Hrs-wks.
• 3. Manifest Illness Phase: Specific syndromes.
  • Hematopoietic (HP): 2-10 Gy. Infection, hemorrhage. Nadir ~3-4 wks.
  • Gastrointestinal (GI): 6-10 Gy. Severe NVD, sepsis. Death ~2 wks.
  • Neurovascular (NV)/CNS: >10-20 Gy. Rapid onset. Ataxia, seizures, coma. Fatal <48 hrs.
• 4. Recovery or Death:
  • HP: Recovery possible. GI/NV: Often fatal.

⭐ The duration of the latent phase is inversely proportional to the radiation dose; higher doses lead to shorter or absent latent periods.

Core Syndromes - Systemic Shockwaves

• Hematopoietic (Bone Marrow) Syndrome (HPS)

  • Dose: ~0.7 - 10 Gy (mild from 0.3 Gy).
  • Mechanism: Bone marrow stem cell destruction → pancytopenia.
  • Nadir: Lymphocytes (1-2 days), Neutrophils (3-5 wks), Platelets (3-5 wks).
  • Features: Infection (neutropenia), hemorrhage (thrombocytopenia), anemia.
  • Outcome: Death at >2 Gy if untreated (infection/hemorrhage). Recovery possible.
  • 📌 Mnemonic: Hematopoietic Problems Start (stem cells).

• Gastrointestinal (GI) Syndrome (GIS)

  • Dose: >6 - 10 Gy (overlaps severe HPS).
  • Mechanism: Crypt cell death → mucosal denudation, villous atrophy → impaired absorption, barrier loss.
  • Features: Severe N/V, bloody diarrhea, dehydration, electrolyte imbalance, sepsis.
  • Outcome: Death in 2 wks (fluid/electrolyte loss, infection). Survival rare >10 Gy.

• Neurovascular / Cardiovascular (NVS/CVS) Syndrome

  • Dose: >20 - 30 Gy (effects >10 Gy; fulminant >50 Gy).
  • Mechanism: Vasculitis, ↑capillary permeability, cerebral edema, direct neuronal/myocardial damage.
  • Features: Rapid: severe N/V, disorientation, ataxia, seizures, coma, hypotension.
  • Outcome: Uniformly fatal in hours to 3 days.

⭐ In the 2-10 Gy whole-body exposure range, the hematopoietic syndrome is dominant, and death, if it occurs, is typically due to infection and/or hemorrhage.

Diagnosis & Management - Battle Plan ARS

• Diagnosis:
  • History of exposure.
  • Clinical: Nausea, Vomiting, Diarrhea (NVD) onset time.
  • Biodosimetry: Serial lymphocyte counts (key prognostic), cytogenetics (dicentrics).
• Management:
  • Triage: Based on symptoms, dose estimation (lymphocyte kinetics).
  • Decontamination: External/internal.
  • Supportive Care: Fluids, antiemetics, antibiotics, transfusions.
  • Cytokines: G-CSF/GM-CSF for doses > 2 Gy.
  • Stem Cell Transplant (SCT): For doses > 6-8 Gy with severe marrow failure.
  • Treat specific organ syndromes (GI, CVS, CNS).

⭐ A rapid fall in absolute lymphocyte count within the first 24-48 hours post-exposure is a key indicator of significant radiation dose and a poor prognostic sign.

High-Yield Points - ⚡ Biggest Takeaways

• Acute Radiation Syndrome (ARS) occurs after whole-body exposure >1 Gy.
• Key phases: Prodromal (NVD), Latent, Manifest Illness.
• Hematopoietic Syndrome (1-6 Gy): Lymphopenia is earliest; death via infection/hemorrhage.
• Gastrointestinal Syndrome (6-10 Gy): Crypt cell death leads to death by sepsis/fluid loss.
• Neurovascular Syndrome (>20-30 Gy): Rapid death from cerebral edema/vasculitis.
• Human LD50/60 is ~3-4 Gy without medical support.
• Early lymphocyte count drop is a crucial prognostic indicator and biodosimeter.